Congressman Chris Collins Announces $225,000 in Federal Funding for Cytocybernetics
June 24, 2019
June 24, 2019
WASHINGTON, June 24 -- Rep. Chris Collins, R-New York, issued the following news release:
Congressman Chris Collins (NY-27) announced $225,000 in federal funding for Cytocybernetics in Tonawanda. This grant was awarded through the National Science Foundation's (NSF) Small Business Technology Transfer (STTR) Phase 1 project which improves the safety testing of new drugs for approval by the FDA.
Cytocybernetics, founded by University of Buffalo medical researchers, develo . . .
Congressman Chris Collins (NY-27) announced $225,000 in federal funding for Cytocybernetics in Tonawanda. This grant was awarded through the National Science Foundation's (NSF) Small Business Technology Transfer (STTR) Phase 1 project which improves the safety testing of new drugs for approval by the FDA.
Cytocybernetics, founded by University of Buffalo medical researchers, develo . . .